A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common

Not Applicable

Completed

• Conditions: Mycoses; Coccidioidomycosis; HIV Infections

• Registration Number: NCT00002325
• Lead Sponsor: Pfizer

Brief Summary

To compare the efficacy of fluconazole versus placebo in preventing the development of active coccidioidomycosis and other systemic fungal infections among HIV-infected patients with CD4 lymphocyte counts \< 250 cells/mm3 who are living in the coccidioidal endemic area.

Detailed Description

Patients are randomized to receive either fluconazole or placebo daily.

Study Timeline

• Status Verified: 1996-04
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (3)

Tucson Veterans Administration Med Ctr; 🇺🇸 Tucson, Arizona, United States

McDowell Clinic; 🇺🇸 Phoenix, Arizona, United States

Dr Lawrence Cone; 🇺🇸 Rancho Mirage, California, United States